Pacira Biosciences, Inc. (PCRX)
19.30
+0.14
(+0.73%)
USD |
NASDAQ |
Jan 20, 16:00
19.32
+0.02
(+0.10%)
After-Hours: 05:40
Pacira Biosciences Total Liabilities (Quarterly): 570.36M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| Hologic, Inc. | 3.967B |
| CorMedix, Inc. | 376.73M |
| Krystal Biotech, Inc. | 102.22M |
| Arcutis Biotherapeutics, Inc. | 212.90M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.298B |
| Shareholders Equity (Quarterly) | 727.21M |
| Debt to Equity Ratio | 0.5848 |
| Current Ratio | 5.256 |
| Net Debt Paydown Yield | 4.03% |